BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20116985)

  • 1. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS).
    Simpson TR; Quezada SA; Allison JP
    Curr Opin Immunol; 2010 Jun; 22(3):326-32. PubMed ID: 20116985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
    Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
    Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ICOS versus CD28 in antiviral immunity.
    Bertram EM; Tafuri A; Shahinian A; Chan VS; Hunziker L; Recher M; Ohashi PS; Mak TW; Watts TH
    Eur J Immunol; 2002 Dec; 32(12):3376-85. PubMed ID: 12432568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
    Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
    Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of activation-inducible lymphocyte immunomediatory molecule/inducible costimulator in the effector function of human T cells: a comparative in vitro study of effects of its blockade and CD28 blockade in human beings and monkeys.
    Tajima N; Tezuka K; Tanaka M; Tanimoto M; Miyai A; Takeshima H; Watanabe Y
    Hum Immunol; 2008 Jul; 69(7):399-408. PubMed ID: 18638655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.
    Frey O; Meisel J; Hutloff A; Bonhagen K; Bruns L; Kroczek RA; Morawietz L; Kamradt T
    Ann Rheum Dis; 2010 Aug; 69(8):1495-501. PubMed ID: 20498202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of inducible costimulator signaling in the development of arteriosclerosis.
    Kosuge H; Suzuki J; Haraguchi G; Koga N; Maejima Y; Inobe M; Isobe M; Uede T
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2660-5. PubMed ID: 16990558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
    Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
    Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice.
    Vidric M; Bladt AT; Dianzani U; Watts TH
    Infect Immun; 2006 Feb; 74(2):1050-61. PubMed ID: 16428752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
    Wong SC; Tan AH; Lam KP
    Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?
    Shilling RA; Bandukwala HS; Sperling AI
    Clin Immunol; 2006 Oct; 121(1):13-8. PubMed ID: 16790364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.
    Khayyamian S; Hutloff A; Büchner K; Gräfe M; Henn V; Kroczek RA; Mages HW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6198-203. PubMed ID: 11983910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICOS is critical for CD40-mediated antibody class switching.
    McAdam AJ; Greenwald RJ; Levin MA; Chernova T; Malenkovich N; Ling V; Freeman GJ; Sharpe AH
    Nature; 2001 Jan; 409(6816):102-5. PubMed ID: 11343122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
    Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
    J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICOS costimulates invariant NKT cell activation.
    Kaneda H; Takeda K; Ota T; Kaduka Y; Akiba H; Ikarashi Y; Wakasugi H; Kronenberg M; Kinoshita K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2005 Feb; 327(1):201-7. PubMed ID: 15629449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function.
    Watanabe S; Ogawa S; Hara Y; Tanabe K; Toma H; Abe R
    Transpl Immunol; 2006 Apr; 15(4):255-63. PubMed ID: 16635747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.